Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT. (NCT07168993)
Detection of Early-Stage Lung Cancer in Sputum Using Flow Cytometry and an Automated Analysis Pipeline
🩺 Plain-English Summary (8th-Grade Level)
Evaluate FlowPath Lung Diagnostic Test of Sputum Samples to Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, \>6 to \<30 mm in Diameter, Determined by LDCT.
Who can join: Review the eligibility criteria below.
Location: VA Palo Alto Health Care System — Palo Alto, California
Age range: 50 Years to 80 Years
🧪 Interventions in This Study
- Standard medical treatment (OTHER)
- Standard medical treatment (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- VA Palo Alto Health Care System — Palo Alto, California
- VA Western Colorado Health Care System — Grand Junction, Colorado
- Bay Pines VA Healthcare System — Bay Pines, Florida
- Miami VA Healthcare System — Miami, Florida
- James A. Haley Veterans' Hospital — Tampa, Florida
- Captain James A. Lovell Federal Health Care Center — North Chicago, Illinois
- Dayton VA Medical Center — Dayton, Ohio
- Clinical Research Associates of Central Pennsylvania — DuBois, Pennsylvania
- Audie Murphy VA Medical Center — San Antonio, Texas
- Brooke Army Medical Center — San Antonio, Texas
- Medical College of Wisconsin — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (210) 698-5334
Email: xr@bioaffinitytech.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer (Diagnosis)
- Margin Intraoperative CT Feedback Feedback Study — Toronto, Ontario
- An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy — Québec, Quebec
- Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1 — Dallas, Texas
- Promoting Radon Testing Among Mothers of Young Children — Bismarck, North Dakota
- Telehealth Collaborative Care Model (CoCM) in Lung Cancer — Philadelphia, Pennsylvania
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study — Boston, Massachusetts
Explore by condition: All Lung Cancer (Diagnosis) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.